Compare McCormick & Company, Incorporated (MKC) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McCormick & Company, Incorporated vs Twist Bioscience Corp — how do they compare? McCormick & Company, Incorporated trades at $52.01 (market cap $14.04B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: McCormick & Company, Incorporated is far larger — about 2.6× Twist Bioscience Corp's market cap, and McCormick & Company, Incorporated pays a 3.68% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MKC | TWST | |
|---|---|---|
Market Cap | $14.04B | $5.45B |
Sector | Consumer Staples | Health |
52-Week High | $72.81 | $102.88 |
52-Week Low | $45.60 | $24.16 |
Enterprise Value | $18.65B | $5.37B |
Dividend Yield | 3.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McCormick & Company, Incorporated
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
